Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind random... by Zhang, Li, Prof, Ma, Shenglin, MD, Song, Xiangqun, MSc, Han, Baohui, MD, Cheng, Ying, MSc, Huang, Cheng, MD, Yang, Shujun, MD, Liu, Xiaoqing, MD, Liu, Yunpeng, MD, Lu, Shun, MD, Wang, Jie, MD, Zhang, Shucai, MD, Zhou, Caicun, MD, Zhang, Xiangwei, MD, Hayashi, Nobuya, BA, Wang, Mengzhao, MD

Get full text

Phase 1 Study of the Selective c-MET Inhibitor, HS-10241, in Patients With Advanced Solid Tumors by Dong, Xiaorong, Li, Xingya, Chen, Jianhua, Ma, Shenglin, Mu, Deguang, Hu, Jie, Lu, Shun

Get full text

Multiplexed Serum Biomarkers for the Detection of Lung Cancer by Ma, Shenglin, Wang, Wenzhe, Xia, Bing, Zhang, Shirong, Yuan, Haining, Jiang, Hong, Meng, Wen, Zheng, Xiaoliang, Wang, Xiaoju

Get full text